Related Experiment Video
Updated: Jul 19, 2025

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Long-Term Outcomes of a Comprehensive Mobile Smoking Cessation Program With Nicotine Replacement Therapy in Adult
Jennifer D Marler1, Craig A Fujii1, MacKenzie T Utley1
1Pivot Health Technologies, Inc, San Carlos, CA, United States.
The Pivot mobile smoking cessation program demonstrated durable effectiveness up to 52 weeks in a pilot randomized controlled trial. This digital health intervention significantly improved abstinence rates and self-efficacy for adult smokers.
Area of Science:
- Digital Health Interventions
- Behavioral Science
- Public Health
Background:
- Smartphone adoption has spurred mobile smoking cessation programs.
- Evidence from randomized controlled trials (RCTs) is growing, but long-term data on cessation durability is needed.
Purpose of the Study:
- To compare 52-week smoking cessation outcomes between the mobile program Pivot and a control (QuitGuide).
- To assess secondary outcomes including smoking behaviors, participant feedback, and factors associated with cessation.
Main Methods:
- A remote pilot randomized controlled trial (RCT) involving 188 adult smokers in the US.
- Participants received 12 weeks of free nicotine replacement therapy (NRT) and were randomized to Pivot or QuitGuide.
- Outcomes included self-reported and biochemically confirmed abstinence, quit attempts, cigarettes per day (CPD), self-efficacy, and participant feedback.
Main Results:
- The Pivot group showed significantly higher rates of biochemically confirmed abstinence (31% vs 18%) and continuous abstinence (19% vs 9%) at 52 weeks.
- Pivot participants reported higher self-efficacy, while QuitGuide participants made more quit attempts and achieved greater CPD reduction.
- Both programs were perceived positively by participants who achieved abstinence.
Conclusions:
- The Pivot mobile smoking cessation program shows sustained effectiveness for long-term smoking cessation.
- This pilot study supports the use of mobile health interventions for durable smoking cessation outcomes.
More Related Videos
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
09:50Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drug Dependence
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Longitudinal Research
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation